Viking Therapeutics Inc’s recently made public that its Director MACARTNEY LAWSON unloaded Company’s shares for reported $0.14 million on Nov 08 ’24. In the deal valued at $68.67 per share,2,000 shares were sold. As a result of this transaction, MACARTNEY LAWSON now holds 47,965 shares worth roughly $2.38 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, LAWSON MACARTNEY bought 2,000 shares, generating $137,333 in total proceeds.
Before that, ZANTE GREG sold 131,687 shares. Viking Therapeutics Inc shares valued at $10,089,164 were divested by the Chief Financial Officer at a price of $76.61 per share. As a result of the transaction, ZANTE GREG now holds 149,366 shares, worth roughly $7.41 million.
H.C. Wainwright reiterated its Viking Therapeutics Inc [VKTX] rating to a Buy in a research note published on November 04, 2024; the price target was $102. A number of analysts have revised their coverage, including JP Morgan’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. Morgan Stanley began covering VKTX with “an Overweight” recommendation on June 27, 2024. Raymond James revised its rating on May 16, 2024. It rated VKTX as “a Strong buy” which previously was an “an Outperform”.
Price Performance Review of VKTX
On Friday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock fall -7.45% to $49.58. Over the last five days, the stock has lost -27.60%. Viking Therapeutics Inc shares have risen nearly 166.42% since the year began. Nevertheless, the stocks have risen 349.50% over the past one year. While a 52-week high of $99.41 was reached on 02/28/24, a 52-week low of $10.34 was recorded on 01/03/24. SMA at 50 days reached $64.60, while 200 days put it at $61.75.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 47.97, which if violated will result in even more drops to 46.37. On the upside, there is a resistance level at 52.19. A further resistance level may holdings at 54.81. The Relative Strength Index (RSI) on the 14-day chart is 31.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -11.78, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.01%. Stochastics %K at 1.31% indicates the stock is a buying.
How much short interest is there in Viking Therapeutics Inc?
A steep rise in short interest was recorded in Viking Therapeutics Inc stocks on 2024-10-31, dropping by -1.2 million shares to a total of 13.28 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 14.48 million shares. There was a decline of -9.02%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 26, 2024 when Oppenheimer resumed its ‘”an Outperform”‘ rating for the stock and retained the price target to $138.
